Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis

Chest

Volumn 129, Issue 5, 2006, Pages 1246-1252

  Handa, Tomohiro ^a   Nagai, Sonoko ^a   Miki, Shinji ^c   Fushimi, Yasutaka ^a   Ohta, Kosuke ^b   Mishima, Michiaki ^a   Izumi, Takateru ^b  

^a KYOTO UNIVERSITY   (Japan)

^b Central Clinic in Kyoto   (Japan)

^c MITSUBISHI KYOTO HOSPITAL   (Japan)

Author keywords

CT; Epidemiology; Pulmonary function test; Pulmonary hypertension; Sarcoidosis

Indexed keywords

ADULT; APPARATUS; ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEVICE; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOGRAPHY; EVALUATION; FEMALE; FOLLOW UP; FUNCTIONAL RESIDUAL CAPACITY; GENDER; HUMAN; IMAGE ANALYSIS; JAPAN; LUNG ARTERY PRESSURE; LUNG FUNCTION TEST; LYMPH NODE HYPERPLASIA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON PARTICIPANT OBSERVATION; OUTPATIENT DEPARTMENT; OXYGEN SATURATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RISK ASSESSMENT; RISK FACTOR; SARCOIDOSIS; SEX DIFFERENCE; SYSTOLE; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; VITAL CAPACITY;

EID: 33646490401     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.5.1246     Document Type: Article

References (26)

1. Shorr AF, Davies DB, Nathan SD. Predicting mortality in patients with sarcoidosis awaiting lung transplantation. Chest 2003; 124:922-928
2. Battesti JP, Georges R, Basset F, et al. Chronic cor pulmonale in pulmonary sarcoidosis. Thorax 1978; 33:76-84
3. Gluskowski J, Hawryllaewicz I, Zych D, et al. Pulmonary haemodynamics at rest and during exercise in patients with sarcoidosis. Respiration 1984; 46:26-32
4. Gluskowski J, Hawrylkiewicz I, Zych D, et al. Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis. Eur Respir J 1990; 3:403-407
5. Rizzato G, Pezzano A, Sala G, et al. Right heart impairment in sarcoidosis: haemodynamic and echocardiographic study. Eur J Respir Dis 1983; 64:121-128
6. Mitchell DN, Scadding JG. Sarcoidosis. Am Rev Respir Dis 1974; 110:774-802
7. Shorr AF, Helman DL, Davies DB, et al. Pulmonary hypertension in advanced sarcoidosis: epidemiology and clinical characteristics. Eur Respir J 2005; 25:783-788
8. Smith LJ, Lawrence JB, Katzenstein AA. Vascular sarcoidosis: a rare cause of pulmonary hypertension. Am J Med Sci 1983; 285:38-44
9. Damuth TE, Bower JS, Cho K, et al. Major pulmonary artery stenosis causing pulmonary hypertension in sarcoidosis. Chest 1980; 78:888-891
10. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160:736-755
11. Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984; 70:657-662
12. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66:493-496
13. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981; 27:1922-1925
14. American Thoracic Society. Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144:1202-1218
15. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:1107-1136
16. Baldwin Ede F, Cournand A, Richards DW Jr. Pulmonary insufficiency: I. Physiological classification, clinical methods of analysis, standard values in normal subjects. Medicine (Baltimore) 1948; 27:243-278
17. Berglund E, Birath G, Bjure J, et al. Spirometric studies in normal subjects: I, Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173:185-192
18. Burrows B, Kasik JE, Niden AH, et al. Clinical usefulness of the single-breath pulmonary diffusing capacity test. Am Rev Respir Dis 1961; 84:789-806
19. Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 2003; 167:735-740
20. Homma A, Anzueto A, Peters JI, et al. Pulmonary artery systolic pressures estimated by echocardiogram vs cardiac catheterization in patients awaiting lung transplantation. J Heart Lung Transplant 2001; 20:833-839
21. Rich S, D'Alonzo GE, Dantzker DR, et al. Magnitude and implications of spontaneous hemodynamic variability in primary pulmonary hypertension. Am J Cardiol 1985; 55:159-163
22. Raeside DA, Chalmers G, Clelland J, et al. Pulmonary artery pressure variation in patients with connective tissue disease: 24 hour ambulatory pulmonary artery pressure monitoring. Thorax 1998; 53:857-862
23. Shapiro SM, Oudiz RJ, Cao T, et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 1997; 30:343-349
24. Oudiz RJ, Ginzton L. Pulmonary artery systolic pressure estimated by echocardiogram vs catheterization in patients awaiting lung transplantation. J Heart Lung Transplant 2003; 22:832-833
25. Preston IR, Klinger JR, Landzberg MJ, et al. Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension. Chest 2001; 120:866-872
26. Sulica R, Teirstein AS, Kakarla S, et al. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Chest 2005; 128:1483-1489